The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency
Abstract Colon cancers with mismatch repair deficiency (dMMR) have specific clinicopathologic characteristics compared with mismatch repair proficiency (pMMR); however, the effect of MMR status on the efficiency of neoadjuvant chemotherapy (NCT) remains unclear. In our study, 439 dMMR and 26 pMMR co...
Saved in:
| Main Authors: | Wu Yunlong, Liu Tongtong, Zeng Hua |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.5076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review
by: Hong-Xia Cui, et al.
Published: (2025-05-01) -
Spontaneous regression of advanced transverse colon cancer with deficient mismatch repair: a case report
by: Shinnosuke Harata, et al.
Published: (2023-04-01) -
Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studyResearch in context
by: Liying Zhao, et al.
Published: (2025-09-01) -
This is not Lynch syndrome: lessons from misattributed diagnoses in constitutional mismatch repair deficiency
by: A.H. Mohammad, et al.
Published: (2024-12-01) -
Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer
by: Yat-Fung Chow, et al.
Published: (2023-10-01)